French MP Mathilde Panot announced on 5 October 2026 that she would not wear the October pink ribbon. In her statement she denounced what she called the "absolute cynicism" behind the campaign, suggesting that the symbol’s origins were tied to corporate interests. She further argued that tracing the ribbon’s history through a series of mergers leads to the agro‑chemical giant Syngenta, implying that the movement serves commercial rather than purely health motives.
Panot also highlighted epidemiological data, noting that France ranks second worldwide in breast‑cancer cases. She pointed out that the pink ribbon has been present in France since 1994, a fact echoed by fellow lawmaker Sarah El Haïry who said, « le Ruban Rose existe en France depuis 1994, bien avant Macron ». The awareness month itself was launched in the United States in 1985, and the ribbon symbol originated in 1992. These chronological markers were invoked to question how long the campaign has really been shaping public discourse.
The refusal drew a sharp reaction from Marine Le Pen, who accused Panot of antisemitism, a charge that intensified the political tenor of the exchange. Another legislator, Aurore Bergé, responded with the pointed remark, « Vous n'avez jamais honte ? », underscoring the moral dimension of the dispute.
The refusal drew a sharp reaction from Marine Le Pen, who accused Panot of antisemitism, a charge that intensified the political tenor of the exchange.
Amid the polemics, a figure of 1.5 lakh lakh was cited in discussions about the scale of the issue, though its precise meaning remained opaque. Panot reinforced her epidemiological claim by stating, « la France est le deuxième pays au monde le plus touché par les cancers du sein », linking the statistical ranking to her critique of the ribbon’s legitimacy.
On 5 October 2026, Panot made her refusal public. Later the same day, Marine Le Pen issued her response, framing the episode as a matter of principle. Five days afterward, on 10 October 2026, an analysis of the pink ribbon was published, attempting to dissect the symbol’s origins and its entanglements with industry and politics.
She declared, « la lutte contre le cancer du sein mérite mieux que des approximations scientifiques et des polémiques politiques », urging that the fight against breast cancer rise above scientific approximations and political polemics. As the debate continues, the clash over a simple ribbon reveals deeper questions about how health campaigns are perceived, funded and politicised in contemporary France.